WATTANAPAT Price to Sales

<div class='circular--portrait' style='background:#FF6600;color: #FFFAFA;font-size:4em;padding-top: 25px;;'>WH</div>
WATTANAPAT HOSPITAL price to sales fundamental analysis lookup allows you to check this and other indicators for WATTANAPAT HOSPITAL TRANG or any other equity instrument. You can also select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please continue to Equity Screeners to view more equity screening tools

Search Price to Sales

 
Refresh

WATTANAPAT Price to Sales Analysis

Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Wattanapat Hospital Trang Public Company Limited owns and operates hospitals and clinics in Thailand. Wattanapat Hospital Trang Public Company Limited was founded in 1957 and is headquartered in Trang, Thailand. WATTANAPAT HOSPITAL operates under Medical Care classification in Thailand and is traded on Stock Exchange of Thailand.
P/S 
 = 
MV Per Share 
Revenue Per Share 
More About Price to Sales | All Equity Analysis

Current WATTANAPAT HOSPITAL TRANG Price to Sales

2.26 

About Price to Sales

The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales. Compare to competition
Based on latest financial disclosure the price to sales indicator of WATTANAPAT HOSPITAL TRANG is roughly 2.26 times. This is 89.44% lower than that of the Healthcare sector, and 8.13% lower than that of Medical Care industry, The Price to Sales for all stocks is 80.21% higher than the company.

Did you try this?

Run Positions Ratings Now

   

Positions Ratings

Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
All  Next Launch Module

WATTANAPAT Fundamentals



 
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page